microRNA-874 suppresses tumor proliferation and metastasis in hepatocellular carcinoma by targeting the DOR/EGFR/ERK pathway Yi Zhang et al, 2018, Cell Death Dis CrossRef
RAS-mediated oncogenic signaling pathways in human malignancies Abdul Q. Khan et al, 2018, Seminars in Cancer Biology CrossRef
The role of enhancer of zeste homolog 2: From viral epigenetics to the carcinogenesis of hepatocellular carcinoma Luca Sanna et al, 2018, J Cell Physiol CrossRef
STIP1 is over-expressed in hepatocellular carcinoma and promotes the growth and migration of cancer cells Xiaoling Luo et al, 2018, Gene CrossRef
Role of the ERK1/2 Signaling Pathway in the Replication of Junín and Tacaribe Viruses Jesús Brunetti et al, 2018, Viruses CrossRef
Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis. Eunjeong Kim et al, 2018, Hepatology CrossRef
Identification of inhibitors synergizing gemcitabine sensitivity in the squamous subtype of pancreatic ductal adenocarcinoma (PDAC) Jia Lin Er et al, 2018, Apoptosis CrossRef
Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas Veerabrahma Pratap Seshachalam et al, 2018, Journal of Gastroenterology and Hepatology CrossRef
An ethyl acetate fraction of Artemisia capillaris
(ACE-63) induced apoptosis and anti-angiogenesis via inhibition of PI3K/AKT signaling in hepatocellular carcinoma Kyung Hee Jung et al, 2018, Phytotherapy Research CrossRef
USP22 promotes resistance to EGFR-TKIs by preventing ubiquitination-mediated EGFR degradation in EGFR-mutant lung adenocarcinoma Huijuan Zhang et al, 2018, Cancer Letters CrossRef
CRISPR-Cas9 therapies in experimental mouse models of cancer Diogo Estêvão et al, 2018, Future Oncology CrossRef
Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma Ozlem Kutlu et al, 2018, Canadian Journal of Gastroenterology and Hepatology CrossRef
Identification of eight meta-signature miRNAs as potential biomarkers for Oropharyngeal Cancers Bo Li et al, 2018, Cancer Genetics CrossRef
Molecular Action of Herbal Antioxidants in Regulation of Cancer Growth: Scope for Novel Anticancer Drugs Manjula Vinayak, 2018, Nutrition and Cancer CrossRef
Dual functions for OVAAL in initiation of RAF/MEK/ERK prosurvival signals and evasion of p27-mediated cellular senescence Ben Sang et al, 2018, Proc Natl Acad Sci USA CrossRef
Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway Jin Sun et al, 2019, J Cell Biochem CrossRef
Design, synthesis, and anticancer activity of iridium(III) complex-peptide hybrids that contain hydrophobic acyl groups at the N-terminus of the peptide units Kana Naito et al, 2019, Journal of Inorganic Biochemistry CrossRef
NAD(P)H Quinone Dehydrogenase 1 Ablation Inhibits Activation of the Phosphoinositide 3-Kinase/Akt Serine/Threonine Kinase and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Pathways and Blocks Metabolic Adaptation in Hepatocellular Carcinoma. Manali Dimri et al, 2020, Hepatology CrossRef
RRAS2 knockdown suppresses osteosarcoma progression by inactivating the MEK/ERK signaling pathway Kejun Wang et al, 2019, Anti-Cancer Drugs CrossRef
Kinase Inhibitors and Ovarian Cancer null Katopodis et al, 2019, Cancers CrossRef
Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma Jacopo Gavini et al, 2019, Cell Death Dis CrossRef
Sevoflurane induces apoptosis and inhibits the growth and motility of colon cancer in vitro and in vivo via inactivating Ras/Raf/MEK/ERK signaling Xiao Yang et al, 2019, Life Sciences CrossRef
Exploring Proteomic Drug Targets, Therapeutic Strategies and Protein - Protein Interactions in Cancer: Mechanistic View Khalid Bashir Dar et al, 2019, CCDT CrossRef
miR‐4510 blocks hepatocellular carcinoma development through
RAF1
targeting and RAS/RAF/MEK/ERK signalling inactivation
Amani Ghousein et al, 2019, Liver Int CrossRef
RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma Shaw M. Akula et al, 2019, Expert Opinion on Therapeutic Targets CrossRef
Current discovery strategies for hepatocellular carcinoma therapeutics Qiuzi Dai et al, 2019, Expert Opinion on Drug Discovery CrossRef
Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma. Nancy S Younis et al, 2019, Sci Rep CrossRef
PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells Junqiang Guo et al, 2020, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
Cyclosporin A activates human hepatocellular carcinoma (HepG2 cells) proliferation: implication of EGFR-mediated ERK1/2 signaling pathway Mohammed E. Abo-El Fetoh et al, 2020, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
SSIPe: accurately estimating protein–protein binding affinity change upon mutations using evolutionary profiles in combination with an optimized physical energy function Xiaoqiang Huang et al, 2019 CrossRef
Apigenin, A Plant Flavone Playing Noble Roles in Cancer Prevention Via Modulation of Key Cell Signaling Networks Deepti Singh et al, 2020, PRA CrossRef
Single high dose irradiation induces cell cycle arrest and apoptosis in human hepatocellular carcinoma cells through the Ras/Raf/MEK/ERK pathways XiaoQiang Tian et al, 2020, International Journal of Radiation Biology CrossRef
Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons Jaitip Tipanee et al, 2020, Molecular Therapy - Nucleic Acids CrossRef
Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma. Manali Dimri et al, 2020, Cancers (Basel) CrossRef
Oxymatrine Inhibits Proliferation and Migration of Vulvar Squamous Cell Carcinoma Cells via Attenuation of the RAS/RAF/MEK/ERK Pathway
Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem Yanling Liu et al, 2020, Nanoscale Res Lett CrossRef
Progress in the correlation between PTPN12 gene expression and human tumors Yu-hu Huo et al, 2020 CrossRef
Potential dual functional roles of the Y‐linked RBMY in hepatocarcinogenesis Tatsuo Kido et al, 2020, Cancer Sci CrossRef
Treatment with a New Barbituric Acid Derivative Exerts Antiproliferative and Antimigratory Effects against Sorafenib Resistance in Hepatocellular Carcinoma Yi-Jen Liao et al, 2020, Molecules CrossRef
Bone mesenchymal stem cells are recruited via CXCL8‐CXCR2 and promote EMT through TGF‐β signal pathways in oral squamous carcinoma Lin Meng et al, 2020, Cell Prolif CrossRef
Enhanced anti-hepatoma effect of a novel curcumin analog C086 via solid dispersion technology Yanping Deng et al, 2020, Drug Delivery CrossRef
Miltirone induces cell death in hepatocellular carcinoma cell through GSDME-dependent pyroptosis. Xiaowei Zhang et al, 2020, Acta Pharm Sin B CrossRef
Integration of RNA-seq and RNAi provides a novel insight into the immune responses of Epinephelus coioides to the impB gene of Pseudomonas plecoglossicida Zixu Liu et al, 2020, Fish & Shellfish Immunology CrossRef
ERK/MAPK signalling pathway and tumorigenesis. Yan-Jun Guo et al, 2020, Exp Ther Med CrossRef
Resolvin D1 inhibits the proliferation of lipopolysaccharide‑treated HepG2 hepatoblastoma and PLC/PRF/5 hepatocellular carcinoma cells by targeting the MAPK pathway You Lu et al, 2018, Exp Ther Med CrossRef
The coordinated effects of Apatinib and Tripterine on the proliferation, invasiveness and apoptosis of human hepatoma Hep3B cells Huihui Li et al, 2018, Oncol Lett CrossRef
Sphingosine-1-phosphate promotes PDGF-dependent endothelial progenitor cell angiogenesis in human chondrosarcoma cells Chao-Qun Wang et al, 2019, Aging CrossRef
Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma Md Gulam Musawwir Khan et al, 2020, BMC Cancer CrossRef
Extract Derived from Cedrus atlantica Acts as an Antitumor Agent on Hepatocellular Carcinoma Growth In Vitro and In Vivo. Gwo-tarng Sheu, 0 CrossRef
Overexpression of Galectin-1 and Galectin-3 in hepatocellular carcinoma Tahereh Setayesh et al, 2020, Liver Research CrossRef
Sophoridine suppresses lenvatinib‐resistant hepatocellular carcinoma growth by inhibiting RAS/MEK/ERK axis via decreasing VEGFR2 expression Zhongwei Zhao et al, 2020, J Cell Mol Med CrossRef
Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease Diwakar Suresh et al, 2020, Front. Oncol. CrossRef
Melatonin inhibiting the survival of human gastric cancer cells under ER stress involving autophagy and Ras-Raf-MAPK signalling. Yongye Huang et al, 2021, J Cell Mol Med CrossRef
Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers J. Wu et al, 2021, Invest New Drugs CrossRef
Prognostic Nomogram for Sorafenib Benefit in Hepatitis B Virus-Related Hepatocellular Carcinoma After Partial Hepatectomy Wei Dong et al, 2021, Front. Oncol. CrossRef
Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma Daryl Ramai et al, 2021, Biomedicines CrossRef
High Expression of LINC01268 is Positively Associated with Hepatocellular Carcinoma Progression via Regulating MAP3K7 Xiuli Jin et al, 2021, OTT CrossRef
In Pursuit of a Selective Hepatocellular Carcinoma Therapeutic Agent: Novel Thalidomide Derivatives with Antiproliferative, Antimigratory and STAT3 Inhibitory Properties Michael J. Nutt et al, 2021, European Journal of Medicinal Chemistry CrossRef
Longitudinal assessment of B-RAF V595E levels in the peripheral cell-free tumor DNA of a 10-year-old spayed female Korean Jindo dog with unresectable metastatic urethral transitional cell carcinoma for monitoring the treatment response to a RAF inhibitor (sorafenib) Jung-Hyun Kim et al, 2021, Veterinary Quarterly CrossRef
Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Novel Indolylacrylamide Derivatives: Synthesis and Biological Evaluation Mohammed Hawash et al, 2021, Chem. Biodiversity CrossRef
Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway Jiejun Hu et al, 2021, Front. Oncol. CrossRef
Anti‐hepatic fibrosis effects of AD‐2 affecting the Raf–MEK signaling pathway and inflammatory factors in thioacetamide‐induced liver injury Tao Li et al, 2021, Journal of Food Science CrossRef
pH-Responsive Pluronic F127–Lenvatinib-Encapsulated Halogenated Boron-Dipyrromethene Nanoparticles for Combined Photodynamic Therapy and Chemotherapy of Liver Cancer Jingjing Zong et al, 2021, ACS Omega CrossRef
mascRNA and its parent lncRNA MALAT1 promote proliferation and metastasis of hepatocellular carcinoma cells by activating ERK/MAPK signaling pathway Shu-Juan Xie et al, 2021, Cell Death Discov. CrossRef
Hepatocrinology Sanjay Kalra et al, 2021, Medical Sciences CrossRef
Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer Kyung Joo Cho et al, 2021, Translational Oncology CrossRef
Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma☆ Fang Wang et al, 2021, Liver Research CrossRef
Cancer - dysregulation of the cell cycle and transduction of cascade signals Akhmad Madaminov et al, 2021 CrossRef
Targeting molecular signal transduction pathways in hepatocellular carcinoma and its implications for cancer therapy Ishfaq Hassan Mir et al, 2021, Cell Biol Int CrossRef
Emerging treatment modalities for systemic therapy in hepatocellular carcinoma Xin Qing et al, 2021, Biomark Res CrossRef
MAPK /ERK signaling pathway: A potential target for the treatment of intervertebral disc degeneration Hai-Jun Zhang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
Identification of potential targets with high centrality indicated by diethylnitrosamine + thioacetamide-induced hepatocellular carcinoma model Sandhya Hora et al, 2021, J Can Res Ther CrossRef
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery Emilie Crouchet et al, 2021, Nat Commun CrossRef
Cetuximab–siRNA Conjugate Linked Through Cationized Gelatin Knocks Down KRAS G12C Mutation in NSCLC Sensitizing the Cells Toward Gefitinib K. Sreedurgalakshmi et al, 2021, Technol Cancer Res Treat CrossRef
Cysteine‐rich
intestinal protein 1 enhances the progression of hepatocellular carcinoma via Ras signaling
Hong‐Yu He et al, 2021, The Kaohsiung Journal of Medical Sciences CrossRef
Antibody–drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevance M. Murali et al, 2021, Clin Transl Oncol CrossRef
Natural resorcylic acid lactones: a chemical biology approach for anticancer activity Shilpa Kuttikrishnan et al, 2021, Drug Discovery Today CrossRef
Cilostazol Induces Apoptosis and Inhibits Proliferation of Hepatocellular Carcinoma Cells by Activating AMPK Kyeong Hwa Sim et al, 2021, Biotechnol Bioproc E CrossRef
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma. Eun Jin Sun et al, 2021, Biomedicines CrossRef
Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach Ivica Grgurevic et al, 2021, Cancers CrossRef
Sorafenib resistance and autophagy in hepatocellular carcinoma: A concealed threat K Ashokachakkaravarthy et al, 2019, J Cancer Res Pract CrossRef
Recent Progress in Lymphangioma Xiaowei Liu et al, 2021, Front. Pediatr. CrossRef
The Research Progress of Trastuzumab-Induced Cardiotoxicity in HER-2-Positive Breast Cancer Treatment Mengmeng Lin et al, 2022, Front. Cardiovasc. Med. CrossRef
Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable Outcome Dirk Andreas Ridder et al, 2022, Cancers CrossRef
c-Met up-regulates the expression of PD-L1 through MAPK/NF-κBp65 pathway Ruyue Xu et al, 2022, J Mol Med CrossRef
Qa-1b functions as an oncogenic factor in mouse melanoma cells Xiang Guo et al, 2022, Journal of Dermatological Science CrossRef
Identifying Potential New Gene Expression-Based Biomarkers in the Peripheral Blood Mononuclear Cells of Hepatitis B-Related Hepatocellular Carcinoma Vahdat Poortahmasebi et al, 2022, Canadian Journal of Gastroenterology and Hepatology CrossRef
PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition Yang Yang et al, 2022, J Exp Clin Cancer Res CrossRef
Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF/MEK/ERK pathway Ying Zhang et al, 2022, npj Breast Cancer CrossRef
HIV-1-Mediated Acceleration of Oncovirus-Related Non-AIDS-Defining Cancers Jessica Proulx et al, 2022, Biomedicines CrossRef
Context dependent role of p53 during the interaction of hepatocellular carcinoma and endothelial cells Shaikh Maryam Ghufran et al, 2022, Microvascular Research CrossRef
Novel antiproliferative agents bearing substituted thieno[2,3-d]pyrimidine scaffold as dual VEGFR-2 and BRAF kinases inhibitors and apoptosis inducers; design, synthesis and molecular docking Rasha A. Hassan et al, 2022, Bioorganic Chemistry CrossRef
Identification of Context-Specific Fitness Genes Associated With Metabolic Rearrangements for Prognosis and Potential Treatment Targets for Liver Cancer Shizhe Yu et al, 2022, Front. Genet. CrossRef
Network Pharmacology-Based Strategy to Investigate the Mechanisms of Lenvatinib in the Treatment of Hepatocellular Carcinoma P. Liu et al, 2022, Computational Intelligence and Neuroscience CrossRef
Targeting the effect of sofosbuvir on selective oncogenes expression level of hepatocellular carcinoma Ras/Raf/MEK/ERK pathway in Huh7 cell line Muhammad Atif et al, 2022, Saudi Journal of Biological Sciences CrossRef
miRCom: Tensor completion integrating multi-view information to deduce the potential disease-related miRNA-miRNA pairs Pei Liu et al, 2020, IEEE/ACM Trans. Comput. Biol. and Bioinf. CrossRef
Research Progresses of Targeted Therapy and Immunotherapy for Hepatocellular Carcinoma Tao Wang et al, 2021, CMC CrossRef
Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram Gong Zhang et al, 2022, Front. Oncol. CrossRef
Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways. Hongjin Chen et al, 2021, Cancer Gene Ther CrossRef
Natural Antioxidant, Antibacterial, and Antiproliferative Activities of Ethanolic Extracts from Punica granatum L. Tree Barks Mediated by Extracellular Signal-Regulated Kinase Arpron Leesombun et al, 2022, Plants CrossRef
Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities Dongliao Fu et al, 2022, Translational Oncology CrossRef
Inhibitory Effect of miR-504-Loaded Magnetic Iron Oxide Nanoparticles on Oral Cancer Through Regulation of Cyclin-Dependent Kinase 6 to Mediate Extracellular Regulated Kinase Signaling Pathway Jing Yu et al, 2022, sci adv mater CrossRef
NEIL3
promotes hepatoma epithelial–mesenchymal transition by activating the
BRAF
/
MEK
/
ERK
/
TWIST
signaling pathway
Hui‐Huang Lai et al, 2022, The Journal of Pathology CrossRef
MEK-inhibitors in treatment of Langerhans cell histiocytosis E. A. Burtsev et al, 2022, Ross. ž. det. gematol. onkol. CrossRef
Therapeutic targeting of hepatocellular carcinoma cells with antrocinol, a novel, dual-specificity, small-molecule inhibitor of the KRAS and ERK oncogenic signaling pathways Chia-Hung Hsu et al, 2022, Chemico-Biological Interactions CrossRef
Multiomics Integration at Single-Cell Resolution Using Bayesian Networks: A Case Study in Hepatocellular Carcinoma Muntadher Jihad et al, 2023, OMICS: A Journal of Integrative Biology CrossRef
Role of
HIF
‐1α in pathogenic mechanisms of keloids
Zi‐kai Qiu et al, 2023, J of Cosmetic Dermatology CrossRef
Bone tumor-homing nanotherapeutics for prolonged retention in tumor microenvironment and facilitated apoptotic process via mevalonate pathway inhibition Nae-Won Kang et al, 2023, Materials Today Bio CrossRef
Berberine Inhibits Endothelial Cell Proliferation via Repressing ERK1/2 Pathway Xiaoqing Wen et al, 2023, Natural Product Communications CrossRef
Autophagy orchestrates resistance in hepatocellular carcinoma cells Homeyra Seydi et al, 2023, Biomedicine & Pharmacotherapy CrossRef
The Role of Metformin as Chemopreventive Strategies for Hepatocellular Carcinoma Ulfa Kholili et al, 2023, RJPT CrossRef
Bone Tumor-Homing Nanotherapeutics for Prolonged Retention in Tumor Microenvironment and Facilitated Apoptotic Process Via Mevalonate Pathway Inhibition Nae-Won Kang et al, 2022, SSRN Journal CrossRef
HEPATOCELLULAR CARCINOMA IN A LARGE COHORT OF TYPE 2 DIABETES PATIENTS Carlo B. Giorda et al, 2023, Diabetes Research and Clinical Practice CrossRef
Exploring the molecular mechanism of glycyrrhetinic acid in the treatment of gastric cancer based on network pharmacology and experimental validation Xia Li et al, 2023, Aging CrossRef
Saikosaponin D exerts cytotoxicity on human endometrial cancer ishikawa cells by inducing apoptosis and inhibiting metastasis through MAPK pathways Tong-Tong Tang et al, 2023, Food and Chemical Toxicology CrossRef
Rational Design, Synthesis and Structural Characterization of Peptides and Peptidomimetics to target Hsp90/Cdc37 Interaction for Treating Hepatocellular Carcinoma Surya Sukumaran et al, 2023, Computational and Structural Biotechnology Journal CrossRef